127,202 Shares in Danaher Co. (NYSE:DHR) Purchased by Imprint Wealth LLC

Imprint Wealth LLC bought a new stake in Danaher Co. (NYSE:DHR) during the second quarter, HoldingsChannel reports. The institutional investor bought 127,202 shares of the conglomerate’s stock, valued at approximately $12,720,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of DHR. Silicon Valley Capital Partners purchased a new position in shares of Danaher during the 1st quarter valued at $29,000. Raleigh Capital Management Inc. boosted its position in Danaher by 68.9% during the first quarter. Raleigh Capital Management Inc. now owns 125 shares of the conglomerate’s stock worth $32,000 after purchasing an additional 51 shares during the period. IAG Wealth Partners LLC raised its position in shares of Danaher by 344.8% in the second quarter. IAG Wealth Partners LLC now owns 129 shares of the conglomerate’s stock valued at $31,000 after purchasing an additional 100 shares during the period. First Capital Advisors Group LLC. purchased a new stake in shares of Danaher during the 2nd quarter valued at approximately $32,000. Finally, America First Investment Advisors LLC bought a new position in Danaher in the 1st quarter worth approximately $34,000. 76.71% of the stock is owned by institutional investors.

Danaher Trading Up 1.2 %

Shares of Danaher stock traded up $2.58 during trading on Monday, reaching $210.36. The company’s stock had a trading volume of 954,367 shares, compared to its average volume of 2,932,010. The company has a market cap of $155.44 billion, a price-to-earnings ratio of 26.20, a PEG ratio of 2.08 and a beta of 0.81. The firm’s 50-day moving average is $217.93 and its two-hundred day moving average is $234.72. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $281.54. The company has a quick ratio of 1.94, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 24th. The conglomerate reported $2.02 EPS for the quarter, topping the consensus estimate of $1.83 by $0.19. Danaher had a return on equity of 13.71% and a net margin of 20.01%. The firm had revenue of $6.87 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the previous year, the business earned $2.56 earnings per share. The company’s quarterly revenue was down 10.3% on a year-over-year basis. On average, sell-side analysts anticipate that Danaher Co. will post 8.36 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were given a $0.27 dividend. The ex-dividend date was Wednesday, October 11th. This represents a $1.08 annualized dividend and a yield of 0.51%. Danaher’s payout ratio is currently 13.62%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on DHR shares. JPMorgan Chase & Co. cut their price target on Danaher from $260.00 to $250.00 and set an “overweight” rating for the company in a report on Wednesday, October 25th. StockNews.com initiated coverage on Danaher in a report on Wednesday, November 15th. They set a “buy” rating for the company. Stifel Nicolaus lowered their price target on shares of Danaher from $250.00 to $240.00 and set a “hold” rating on the stock in a report on Wednesday, July 26th. Bank of America upped their target price on shares of Danaher from $250.00 to $280.00 in a report on Wednesday, July 26th. Finally, Wells Fargo & Company cut their price target on shares of Danaher from $285.00 to $247.00 and set an “overweight” rating for the company in a report on Tuesday, October 3rd. Three investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $257.73.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.